General Home Investors News

The EIB Reaffirms Confidence in Medincell by Permanently Waiving Two Financial Covenants in its Loan Agreement

By MedincellFebruary 6, 2025No Comments

The EIB Reaffirms Confidence in Medincell by Permanently Waiving Two Financial Covenants in its Loan Agreement

February 6, 2025

Previous PostCompletion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia
Next PostUZEDY® Surges to $117M in Sales in 2024, First Full Year of Commercialization

Better medicine for all

Website by ScreenUp